Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
---|
10/05/2011 | CN102204967A Preparation method for safflower care-free tablet |
10/05/2011 | CN102204960A Chinese medicinal composition for treating hepatopathy and preparation method thereof |
10/05/2011 | CN102204951A Method for extracting active components from licorice |
10/05/2011 | CN102204950A Method for extracting flavonoid from liquorice waste residue |
10/05/2011 | CN102204939A Method for preparing pomegranate peel polyphenol liposome by reverse evaporation method |
10/05/2011 | CN102204883A Promethazine hydrochloride microenema prescription and preparation method thereof |
10/05/2011 | CN102204874A Anti-halitosis toothpaste containing natural drug compound components |
10/05/2011 | CN101961417B Preparation method of tablet for curing laryngalgia |
10/05/2011 | CN101920001B Finger-print quality determination method on wuji powder preparation and intermediate thereof |
10/05/2011 | CN101850025B Foot bathing effervescent tablets for warming and invigorating kidney deficiency |
10/05/2011 | CN101837085B Foot-bath effervescent tablet for improving constipation |
10/05/2011 | CN101829210B Method for preparing apple polyphenol |
10/05/2011 | CN101810643B Goose gall extract, preparation method and medicine use thereof |
10/05/2011 | CN101785831B Preparation method of rice bran dietary fiber |
10/05/2011 | CN101757298B Process for extracting and purifying tianschanica maxim total flavonoid |
10/05/2011 | CN101705005B Method for modifying performance of compound resin by using tetrapod-like zinc oxide whiskers |
10/05/2011 | CN101703691B Chinese medicinal composition for treating gastrointestinal ulcer and hemorrhage, and preparation method thereof |
10/05/2011 | CN101703632B Chinese medicament for treating chronic hepatitis B |
10/05/2011 | CN101703554B Preparation and use of semen cuscutae flavonoids |
10/05/2011 | CN101700337B Oral traditional Chinese medicine composition for treating chronic gastritis |
10/05/2011 | CN101618123B Medicated wine for supplementing qi and strengthening kidney |
10/05/2011 | CN101564430B Oral solution for treating constipation |
10/05/2011 | CN101537062B Stomach-clearing decoction of nine ingredients |
10/05/2011 | CN101530469B Method for preparing effective component group of water soluble Chinese cassia tree |
10/05/2011 | CN101502627B Chinese medicine health product preparation for preventing and treating alcoholic liver disease and preparation method thereof |
10/05/2011 | CN101480455B Compound agrimony enteritis tablet and quality detection method thereof |
10/05/2011 | CN101361764B Composition containing brown alga polysaccharide sulfuric ester and glossy ganoderma polysaccharide and use thereof |
10/05/2011 | CN101300229B 1-heterocyclylsulfonyl, 2-aminomethyl, 5- (hetero-) aryl substituted 1-h-pyrrole derivatives as acid secretion inhibitors |
10/05/2011 | CN101297880B Active extract containing phlorizin and uses thereof |
10/05/2011 | CN101268848B Dew concentration beverage |
10/05/2011 | CN101249217B Externally used mongolian medicine patch and preparing method for curing children's anorexia |
10/05/2011 | CN101194905B Dropping pills containing domperidone and method for preparing the same |
10/05/2011 | CN101172132B Self-emulsifying preparations for treating gastropathy and preparation method thereof |
10/05/2011 | CN101147792B Method for preparing capsule for treating hepatitis B, clearing heat and antitoxic |
10/05/2011 | CN101066981B Non-cyclic nucleoside phosphonate compound and its composition, prepn process and use |
10/05/2011 | CN101032502B Application of centella triterpenes in the preparing of medicine for preventing and curing pancreatic fibrosis |
10/05/2011 | CN101015575B Process for preparing bupleurum root dropping pills |
10/04/2011 | US8030517 CCR9 inhibitors and methods of use thereof |
10/04/2011 | US8030333 Benzimidazole compound crystal |
10/04/2011 | US8030310 Therapeutic agents useful for treating pain |
10/04/2011 | US8030296 Oestrogen-17-sulphamates as inhibitors of steroid sulphatase |
10/04/2011 | US8030275 Methods for treating obesity using fibroblast growth factor-like polypeptides |
10/04/2011 | US8029779 Claims are for a nitrogen oxide sensor electrode and do not match rest of document; Lactobacillus delbrueckii with antifungal activity and use as a probiotic |
10/04/2011 | CA2669481C Substituted 2-(2,6-dioxopiperidin-3-yl)-phthalimides and -1-oxoisoindolines and method of reducing tnf.alpha. levels |
10/04/2011 | CA2491079C Therapeutic piperazine derivatives useful for treating pain |
10/04/2011 | CA2478099C Inhibitors |
10/04/2011 | CA2438520C Phthalazinone-piperidino-derivatives as pde4 inhibitors |
10/04/2011 | CA2371839C Hydroxymatairesinol in cancer prevention |
10/04/2011 | CA2340103C Carbohydrate mixtures |
09/29/2011 | WO2011119738A2 Methods of treatment using stem cell mobilizers |
09/29/2011 | WO2011118976A2 Pharmaceutical composition for the prevention or the treatment of non-alcoholic fatty liver disease and the method for prevention or treatment of non-alcoholic fatty liver disease using the same |
09/29/2011 | WO2011118843A1 Glutamate derivatives or salts thereof |
09/29/2011 | WO2011099000A3 Pharmaceutical composition for treating the gastrointestinal tract |
09/29/2011 | WO2011056793A3 Composition, method, and kit for alpha-1 proteinase inhibitor |
09/29/2011 | WO2011026125A3 Gastric retentive pharmaceutical compositions for immediate and extended release of acetaminophen |
09/29/2011 | US20110238003 Method for systemic drug delivery through the nail |
09/29/2011 | US20110237659 Chromenone derivatives as trpv3 antagonists |
09/29/2011 | US20110237650 Treatment of vascular endothelial growth factor (vegf) related diseases by inhibition of natural antisense transcript to vegf |
09/29/2011 | US20110237649 Treatment of sirtuin 1 (sirt1) related diseases by inhibition of natural antisense transcript to sirtuin 1 |
09/29/2011 | US20110237648 Rna interference in skin indications |
09/29/2011 | US20110237633 Small molecule modulators of hepatocyte growth factor (scatter factor) activity |
09/29/2011 | US20110237619 Imidazopyridine derivatives which inhibit the secretion of gastric acid |
09/29/2011 | US20110237607 Substituted purinyl-pyrazol derivatives and their use as potassium channel modulators |
09/29/2011 | US20110237601 Substituted piperazinyl-pyrrolidine compounds useful as chemokine receptor antagonists |
09/29/2011 | US20110237596 Heteroaryl-substituted urea modulators of fatty acid amide hydrolase |
09/29/2011 | US20110237579 Inhibitors of hcv ns5a |
09/29/2011 | US20110237557 Diastereomers of 2-methylene-19-nor-22-methyl-1alpha,25-dihydroxyvitamin d3 |
09/29/2011 | US20110237534 Methods for treating gastrointestinal diseases |
09/29/2011 | US20110237532 1-[(3-cyano-pyridin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-[3-(r)-amino-piperidin-1-yl]-xanthine for the treatment of a metabolic disorder of a predominantly carnivorous non-human animal |
09/29/2011 | US20110237529 Adenosine Analogs and Their Use |
09/29/2011 | US20110237528 Compositions and methods comprising imidazole and triazole derivatives |
09/29/2011 | US20110237521 Splice switching oligomers for tnf superfamily receptors and their use in treatment of disease |
09/29/2011 | US20110237505 Compositions and Methods for Treating Obesity and Diabetes |
09/29/2011 | US20110237498 Soluble polypeptides for use in treating autoimmune and inflammatory disorders |
09/29/2011 | US20110237496 Antinecrotic activity of alpha 1-antitrypsin |
09/29/2011 | US20110237494 Use of peptidic vasopression receptor agonists |
09/29/2011 | US20110236508 L-arginine-based formulation for oral absorption |
09/29/2011 | US20110236505 Carbohydrate bar |
09/29/2011 | US20110236500 Nutritional supplement with colostrum and epa or dha or gla |
09/29/2011 | US20110236480 Prebiotic formulations and methods of use |
09/29/2011 | US20110236439 Immediate release formulations of 1-aminocyclohexane compounds, memantine and neramexane |
09/29/2011 | US20110236438 Method of treatment of diseases using hoodia extracts |
09/29/2011 | US20110236436 Pharmaceutical composition for modified release |
09/29/2011 | US20110236369 Dosage Forms That Facilitate Rapid Activation of Zymogen |
09/29/2011 | US20110236368 Oral medication for the treatment of hemorrhoids and method of use |
09/29/2011 | US20110236367 Rat cathespin dipeptidyl peptidase i (dppi): crystal structure and its uses |
09/29/2011 | US20110236352 PEGylation by the Dock and Lock (DNL) Technique |
09/29/2011 | DE102010013209A1 Diarrhö-Prophylaktikum Diarrhea prophylactic |
09/29/2011 | CA2793725A1 Carboxamide bioisosteres of opiates |
09/29/2011 | CA2790914A1 Pharmaceutical composition comprising dipeptidyl peptibase-iv inhibitor for the prevention or the treatment of non-alcoholic fatty liver disease and the method for prevention or treatment of non-alcoholic fatty liver disease using the same |
09/28/2011 | EP2368910A1 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
09/28/2011 | EP2368901A1 Peptidomimetic protease inhibitors |
09/28/2011 | EP2368898A1 Compositions and methods for counteracting effects of reactive oxygen species and free radicals |
09/28/2011 | EP2368878A1 Peptidomimetic protease inhibitors |
09/28/2011 | EP2368877A1 Chiral intermediates for the preparation of peptidomimetic protease inhibitors |
09/28/2011 | EP2368577A2 Methods for treating interleukin-6 related diseases |
09/28/2011 | EP2367837A2 1'-substituted ribose 5'-polyphosphate analogs and their use as modulators of p2y receptor activity |
09/28/2011 | EP2367564A1 Norrin in the treatment of diseases associated with an increased tgf-beta activity |
09/28/2011 | EP2367561A1 Compositions and methods for treatment of celiac disease |
09/28/2011 | EP2367557A1 Composition for the treatment of inflammatory diseases of the oral and pharyngeal cavity |